选择性-话题@MedSci

#选择性#

173篇内容 | 1338人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1923002, encodeId=178819230024d, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=JMC | 新型水溶性“唑啉铵”可选择性修饰肽和蛋白的赖氨酸残基, objectType=article, longId=737335, objectId=49f8e3733555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49f8e3733555, replyNumber=0, likeNumber=31, createdTime=2023-03-01, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49f8e3733555, moduleTitle=JMC | 新型水溶性“唑啉铵”可选择性修饰肽和蛋白的赖氨酸残基, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49f8e3733555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1923000, encodeId=639b1923000e3, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=ARD：选择性TYK2抑制剂德卡伐替尼在银屑病关节炎II期试验中的疗效和安全性, objectType=article, longId=730645, objectId=8303e3064580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8303e3064580, replyNumber=0, likeNumber=44, createdTime=2023-02-07, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8303e3064580, moduleTitle=ARD：选择性TYK2抑制剂德卡伐替尼在银屑病关节炎II期试验中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8303e3064580)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1923004, encodeId=cc881923004c5, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, objectType=article, longId=738266, objectId=f13fe3826674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f13fe3826674, replyNumber=0, likeNumber=44, createdTime=2022-09-26, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f13fe3826674, moduleTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f13fe3826674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922995, encodeId=161f192299596, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, objectType=article, longId=300307, objectId=bf2730030e4f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf2730030e4f, replyNumber=0, likeNumber=47, createdTime=2023-02-04, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf2730030e4f, moduleTitle=Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf2730030e4f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1923003, encodeId=f8ca1923003cc, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, objectType=article, longId=737443, objectId=62fae3744324, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62fae3744324, replyNumber=0, likeNumber=49, createdTime=2023-05-30, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62fae3744324, moduleTitle=最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62fae3744324)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922998, encodeId=67d319229989a, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=AACR重磅之PETRA试验：新一代PARP1选择性抑制剂AZD5305在BRCA1/2、PALB2或RAD51C/D突变的患者（pts）中的首次人体试验, objectType=article, longId=723981, objectId=f235e2398163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f235e2398163, replyNumber=0, likeNumber=31, createdTime=2023-01-18, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f235e2398163, moduleTitle=AACR重磅之PETRA试验：新一代PARP1选择性抑制剂AZD5305在BRCA1/2、PALB2或RAD51C/D突变的患者（pts）中的首次人体试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f235e2398163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922997, encodeId=da29192299e75, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=AACR 2022：第二代PARP1选择性抑制剂首次人体试验结果公布, objectType=article, longId=724027, objectId=af24e240278a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af24e240278a, replyNumber=0, likeNumber=44, createdTime=2022-10-20, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af24e240278a, moduleTitle=AACR 2022：第二代PARP1选择性抑制剂首次人体试验结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af24e240278a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922990, encodeId=98a51922990c4, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命, objectType=article, longId=292496, objectId=9cac292496e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cac292496e4, replyNumber=0, likeNumber=38, createdTime=2022-06-23, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cac292496e4, moduleTitle=打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cac292496e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922996, encodeId=5a36192299613, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=选择性雌激素受体降解剂 (SERD) amcenestrant 治疗乳腺癌，未能达到主要终点, objectType=article, longId=300814, objectId=d3a3300814e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a3300814e1, replyNumber=0, likeNumber=51, createdTime=2023-01-06, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a3300814e1, moduleTitle=选择性雌激素受体降解剂 (SERD) amcenestrant 治疗乳腺癌，未能达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a3300814e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922986, encodeId=1821192298680, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Clin Cancer Res：口服选择性雌激素受体降解剂±Ribociclib或Alpelisib治疗ER+乳腺癌的疗效和安全性, objectType=article, longId=216493, objectId=e168216493b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e168216493b8, replyNumber=0, likeNumber=0, createdTime=2021-12-02, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e168216493b8, moduleTitle=Clin Cancer Res：口服选择性雌激素受体降解剂±Ribociclib或Alpelisib治疗ER+乳腺癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e168216493b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922999, encodeId=2ab61922999ef, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, objectType=article, longId=727795, objectId=19a7e27795a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19a7e27795a3, replyNumber=0, likeNumber=62, createdTime=2022-09-29, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19a7e27795a3, moduleTitle=J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19a7e27795a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922989, encodeId=0fef1922989f5, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=JGH：在接受非肠道选择性生物疗法治疗的炎症性肠病患者中COVID-19感染的发生率较低, objectType=article, longId=220592, objectId=5bd6220592f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bd6220592f0, replyNumber=0, likeNumber=36, createdTime=2022-06-03, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bd6220592f0, moduleTitle=JGH：在接受非肠道选择性生物疗法治疗的炎症性肠病患者中COVID-19感染的发生率较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bd6220592f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922988, encodeId=15121922988d7, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Thorax：急性哮喘成人或儿童患者肾上腺素与选择性β-2激动剂的疗效比较, objectType=article, longId=218301, objectId=f9cf21830177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9cf21830177, replyNumber=0, likeNumber=58, createdTime=2021-10-13, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9cf21830177, moduleTitle=Thorax：急性哮喘成人或儿童患者肾上腺素与选择性β-2激动剂的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9cf21830177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922991, encodeId=75ea19229917d, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=探索头条 | 打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命, objectType=article, longId=292620, objectId=f46a292620ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f46a292620ff, replyNumber=0, likeNumber=42, createdTime=2022-11-10, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f46a292620ff, moduleTitle=探索头条 | 打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f46a292620ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922994, encodeId=6515192299498, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Lancet Oncol：鼻咽癌 | 选择性上颈部放疗是否可替代全颈放疗？, objectType=article, longId=300103, objectId=f14b30010366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f14b30010366, replyNumber=0, likeNumber=0, createdTime=2022-04-20, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f14b30010366, moduleTitle=Lancet Oncol：鼻咽癌 | 选择性上颈部放疗是否可替代全颈放疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f14b30010366)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922982, encodeId=ff211922982cd, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Stroke：接受选择性血清素再摄取抑制剂治疗的卒中患者骨折风险如何？, objectType=article, longId=213395, objectId=4a62213395fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a62213395fa, replyNumber=0, likeNumber=56, createdTime=2022-01-02, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a62213395fa, moduleTitle=Stroke：接受选择性血清素再摄取抑制剂治疗的卒中患者骨折风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a62213395fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922978, encodeId=e1a419229e872, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Translational Psychiatry：选择性5 -羟色胺再摄取抑制剂对 22q11.2 缺失综合征患者认知和大脑发育有益, objectType=article, longId=212177, objectId=1a732121e7fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a732121e7fe, replyNumber=0, likeNumber=45, createdTime=2022-03-29, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a732121e7fe, moduleTitle=Translational Psychiatry：选择性5 -羟色胺再摄取抑制剂对 22q11.2 缺失综合征患者认知和大脑发育有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a732121e7fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922993, encodeId=099f19229932e, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系, objectType=article, longId=295132, objectId=a31029513287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a31029513287, replyNumber=0, likeNumber=34, createdTime=2022-08-01, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a31029513287, moduleTitle=Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a31029513287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922992, encodeId=25d4192299245, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=Nat Metab：仙丹在这里！葡萄籽提取物可选择性清除衰老细胞，延长寿命！, objectType=article, longId=292785, objectId=a7d6292e8577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7d6292e8577, replyNumber=0, likeNumber=28, createdTime=2022-09-06, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7d6292e8577, moduleTitle=Nat Metab：仙丹在这里！葡萄籽提取物可选择性清除衰老细胞，延长寿命！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7d6292e8577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1922987, encodeId=25f7192298e19, content=<a href='/topic/show?id=78f794e800a' target=_blank style='color:#2F92EE;'>#选择性#</a>, objectTitle=JNER：选择性神经刺激方法改善脊髓损伤后的自行车运动功能, objectType=article, longId=216837, objectId=f1aa21683e4c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1aa21683e4c, replyNumber=0, likeNumber=31, createdTime=2021-10-04, rootId=0, userName=肉我只吃一口, userId=a0802500050, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1aa21683e4c, moduleTitle=JNER：选择性神经刺激方法改善脊髓损伤后的自行车运动功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1aa21683e4c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

选择性

2020-05-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

JMC | 新型水溶性“唑啉铵”可选择性修饰肽和蛋白的赖氨酸残基

2023-03-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

ARD：选择性TYK2抑制剂德卡伐替尼在银屑病关节炎II期试验中的疗效和安全性

2023-02-07

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？

2022-09-26

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Mayo Clin Proc：成人慢性阻塞性肺疾病心肌梗死后心脏选择性与非选择性β受体阻滞剂的比较

2023-02-04

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

最新中国证据！肠道选择性生物制剂治疗IBD真实世界数据表现如何？

2023-05-30

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

AACR重磅之PETRA试验：新一代PARP1选择性抑制剂AZD5305在BRCA1/2、PALB2或RAD51C/D突变的患者（pts）中的首次人体试验

2023-01-18

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

AACR 2022：第二代PARP1选择性抑制剂首次人体试验结果公布

2022-10-20

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命

2022-06-23

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

选择性雌激素受体降解剂 (SERD) amcenestrant 治疗乳腺癌，未能达到主要终点

2023-01-06

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Clin Cancer Res：口服选择性雌激素受体降解剂±Ribociclib或Alpelisib治疗ER+乳腺癌的疗效和安全性

2021-12-02

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

J Clin Oncol：选择性雌激素受体降解剂（Elacestrant）对比标准内分泌治疗ER+/HR-晚期乳腺癌的疗效：III期临床研究EMERALD

2022-09-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

JGH：在接受非肠道选择性生物疗法治疗的炎症性肠病患者中COVID-19感染的发生率较低

2022-06-03

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Thorax：急性哮喘成人或儿童患者肾上腺素与选择性β-2激动剂的疗效比较

2021-10-13

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

探索头条 | 打疫苗就能延长寿命！ Nature子刊：抗衰老疫苗选择性清除衰老细胞延长寿命

2022-11-10

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Lancet Oncol：鼻咽癌 | 选择性上颈部放疗是否可替代全颈放疗？

2022-04-20

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Stroke：接受选择性血清素再摄取抑制剂治疗的卒中患者骨折风险如何？

2022-01-02

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Translational Psychiatry：选择性5 -羟色胺再摄取抑制剂对 22q11.2 缺失综合征患者认知和大脑发育有益

2022-03-29

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Stroke：选择性5-羟色胺再摄取抑制剂与非心源性缺血性卒中风险的关系

2022-08-01

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

Nat Metab：仙丹在这里！葡萄籽提取物可选择性清除衰老细胞，延长寿命！

2022-09-06

肉我只吃一口 (审核中...)

前往app查看评论内容

#选择性#

JNER：选择性神经刺激方法改善脊髓损伤后的自行车运动功能

2021-10-04

科室
- - 订阅+
  - 更多科室
工具
服务